Bruce Teter - Publications

Affiliations: 
University of California, Los Angeles, Los Angeles, CA 
Area:
Alzheimers aging

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ma QL, Zhu C, Morselli M, Su T, Pelligrini M, Lu Z, Jones M, Denver P, Castro D, Gu X, Relampagos F, Caoili K, Teter B, Frautschy SA, Cole GM. The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models. Frontiers in Immunology. 11: 558036. PMID 33178186 DOI: 10.3389/fimmu.2020.558036  0.305
2020 Hayden EY, Huang JM, Charreton M, Nunez SM, Putman JN, Teter B, Lee JT, Welch A, Frautschy S, Cole G, Teng E, Hinman JD. Modeling Mixed Vascular and Alzheimer's Dementia Using Focal Subcortical Ischemic Stroke in Human ApoE4-TR:5XFAD Transgenic Mice. Translational Stroke Research. PMID 32086779 DOI: 10.1007/S12975-020-00786-0  0.317
2019 Denver P, D'Adamo H, Hu S, Zuo X, Zhu C, Okuma C, Kim P, Castro D, Jones MR, Leal C, Mekkittikul M, Ghadishah E, Teter B, Vinters HV, Cole GM, et al. A Novel Model of Mixed Vascular Dementia Incorporating Hypertension in a Rat Model of Alzheimer's Disease. Frontiers in Physiology. 10: 1269. PMID 31708792 DOI: 10.3389/Fphys.2019.01269  0.363
2019 Cole GM, Verduzco A, Pellegrini MA, Su Y, Ladu MJ, Frautschy SA, Teter B. P2-211: PHARMACOGENOMIC IMPACT OF APOE4 ON TRANSCIPTIONAL REGULATION OF MICROGLIA IN AD MODEL MICE: IMPLICATIONS FOR PREVENTION AND TREATMENT Alzheimer's & Dementia. 15: P658-P658. DOI: 10.1016/J.Jalz.2019.06.2618  0.34
2018 Ma QL, Teng E, Zuo X, Jones M, Teter B, Zhao EY, Zhu C, Bilousova T, Gylys KH, Apostolova LG, LaDu MJ, Hossain MA, Frautschy SA, Cole GM. Neuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer's disease. Neurobiology of Disease. PMID 29501530 DOI: 10.1016/J.Nbd.2018.02.014  0.325
2017 Cole GM, Ma Q, Teter B, Jones M, Frautschy SA. [P3-124]: DIETARY LINOLEIC ACID DIFFERENTIALLY INFLUENCES BRAIN FADS ACTIVITIES INCREASING AN N-6 METABOLITE THAT INHIBITS INFLAMMATION AND PROMOTES AMYLOID-β CLEARANCE Alzheimer's & Dementia. 13: P982-P982. DOI: 10.1016/j.jalz.2017.06.1335  0.324
2016 Teter B, LaDu MJ, Sullivan PM, Frautschy SA, Cole GM. Apolipoprotein ε isotype-dependent modulation of microRNA-146a in plasma and brain. Neuroreport. PMID 27281274 DOI: 10.1097/WNR.0000000000000608  0.368
2013 Ma QL, Zuo X, Yang F, Ubeda OJ, Gant DJ, Alaverdyan M, Teng E, Hu S, Chen PP, Maiti P, Teter B, Cole GM, Frautschy SA. Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice. The Journal of Biological Chemistry. 288: 4056-65. PMID 23264626 DOI: 10.1074/Jbc.M112.393751  0.325
2009 Ma QL, Galasko DR, Ringman JM, Vinters HV, Edland SD, Pomakian J, Ubeda OJ, Rosario ER, Teter B, Frautschy SA, Cole GM. Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Archives of Neurology. 66: 448-57. PMID 19364929 DOI: 10.1001/Archneurol.2009.22  0.373
2008 Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, Rock CL, Pruitt MA, Yang F, Hudspeth B, Hu S, Faull KF, Teter B, Cole GM, Frautschy SA. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. The Journal of Pharmacology and Experimental Therapeutics. 326: 196-208. PMID 18417733 DOI: 10.1124/Jpet.108.137455  0.364
2007 Ma QL, Teter B, Ubeda OJ, Morihara T, Dhoot D, Nyby MD, Tuck ML, Frautschy SA, Cole GM. Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 14299-307. PMID 18160637 DOI: 10.1523/JNEUROSCI.3593-07.2007  0.429
2007 Ma QL, Harris-White ME, Ubeda OJ, Simmons M, Beech W, Lim GP, Teter B, Frautschy SA, Cole GM. Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models. Journal of Neurochemistry. 103: 1594-607. PMID 17760871 DOI: 10.1111/j.1471-4159.2007.04869.x  0.382
2007 Cole GM, Teter B, Frautschy SA. Neuroprotective effects of curcumin. Advances in Experimental Medicine and Biology. 595: 197-212. PMID 17569212 DOI: 10.1007/978-0-387-46401-5_8  0.317
2007 Teter B. Life-span influences of apoE4 on CNS function. Neurobiology of Aging. 28: 693-703; discussion . PMID 17045362 DOI: 10.1016/j.neurobiolaging.2006.06.028  0.357
2007 Cole GM, Ma Q, Yang F, Teter B, Begum A, Frautschy SA. O1-02-08: DHA, amyloid, GSK3β, trophic signaling and AD prevention Alzheimer's & Dementia. 3: S170-S171. DOI: 10.1016/j.jalz.2007.04.094  0.317
2006 Zhao L, Ma QL, Calon F, Harris-White ME, Yang F, Lim GP, Morihara T, Ubeda OJ, Ambegaokar S, Hansen JE, Weisbart RH, Teter B, Frautschy SA, Cole GM. Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nature Neuroscience. 9: 234-42. PMID 16415866 DOI: 10.1038/Nn1630  0.348
2006 Ma QL, Lim GP, Harris-White ME, Yang F, Ambegaokar SS, Ubeda OJ, Glabe CG, Teter B, Frautschy SA, Cole GM. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro. Journal of Neuroscience Research. 83: 374-84. PMID 16385556 DOI: 10.1002/Jnr.20734  0.357
2005 Cole GM, Lim GP, Yang F, Teter B, Begum A, Ma Q, Harris-White ME, Frautschy SA. Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions. Neurobiology of Aging. 26: 133-6. PMID 16266772 DOI: 10.1016/j.neurobiolaging.2005.09.005  0.355
2005 Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, Salem N, Frautschy SA, Cole GM. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 3032-40. PMID 15788759 DOI: 10.1523/JNEUROSCI.4225-04.2005  0.399
2005 Morihara T, Teter B, Yang F, Lim GP, Boudinot S, Boudinot FD, Frautschy SA, Cole GM. Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1111-20. PMID 15688088 DOI: 10.1038/sj.npp.1300668  0.368
2004 Zhao L, Teter B, Morihara T, Lim GP, Ambegaokar SS, Ubeda OJ, Frautschy SA, Cole GM. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 11120-6. PMID 15590928 DOI: 10.1523/Jneurosci.2860-04.2004  0.339
2004 Teter B, Finch CE. Caliban's heritance and the genetics of neuronal aging. Trends in Neurosciences. 27: 627-32. PMID 15374675 DOI: 10.1016/j.tins.2004.08.005  0.497
2004 Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem N, Ashe KH, Frautschy SA, Cole GM. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron. 43: 633-45. PMID 15339646 DOI: 10.1016/j.neuron.2004.08.013  0.391
2004 Teter B. ApoE-dependent plasticity in Alzheimer's disease. Journal of Molecular Neuroscience : Mn. 23: 167-79. PMID 15181245 DOI: 10.1385/JMN:23:3:167  0.387
2004 Dhoot D, Teter B, Cole G. 86 EFFECTS OF DOCOSAHEXAENOIC ACID ON THE EXPRESSION OF LR11 IN MICE; IMPLICATIONS FOR ALZHEIMER'S DISEASE. Journal of Investigative Medicine. 52: S93.5-S93. DOI: 10.1136/JIM-52-SUPPL1-86  0.334
2004 Morihara T, Yang F, Lim G, Teter B, Ambegaokar S, Beech W, Yao J, Abemathy A, Frautschy S, Cole GM. P4-337 Regulation of microglial activation and effects of abeta production by ibuprofen and curcumin, an anti-inflammatory and anti-oxidative compound that suppresses amyloid in TG2576 (APPSW mice) Neurobiology of Aging. 25: S571. DOI: 10.1016/S0197-4580(04)81895-5  0.302
2004 Cole GM, Zhao L, Calon F, Morihara T, Teter B, Ambegaokar S, Yang F, Ashe KH, Frautschy SA. O4-03-05 Dietary omega-3 docosahexaenoic acid DHA regulates CNS insulin signaling and related kinase pathways involved in actin assembly, synaptic plasticity and memory in an Alzheimer (AD) model Neurobiology of Aging. 25: S79. DOI: 10.1016/S0197-4580(04)80268-9  0.323
2002 Teter B, Raber J, Nathan B, Crutcher KA. The presence of apoE4, not the absence of apoE3, contributes to AD pathology. Journal of Alzheimer's Disease : Jad. 4: 155-63. PMID 12226534 DOI: 10.3233/Jad-2002-4305  0.34
2002 Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, Cole GM. Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. Journal of Neuroscience Research. 68: 331-6. PMID 12111863 DOI: 10.1002/jnr.10221  0.379
2001 Harris-White ME, Chu T, Miller SA, Simmons M, Teter B, Nash D, Cole GM, Frautschy SA. Estrogen (E2) and glucocorticoid (Gc) effects on microglia and A beta clearance in vitro and in vivo. Neurochemistry International. 39: 435-48. PMID 11578779 DOI: 10.1016/S0197-0186(01)00051-1  0.334
2000 Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA, Cole GM. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 5709-14. PMID 10908610 DOI: 10.1523/Jneurosci.20-15-05709.2000  0.414
1999 Teter B, Harris-White ME, Frautschy SA, Cole GM. Role of apolipoprotein E and estrogen in mossy fiber sprouting in hippocampal slice cultures. Neuroscience. 91: 1009-16. PMID 10391478 DOI: 10.1016/S0306-4522(98)00630-7  0.325
1999 Krohn K, Rozovsky I, Wals P, Teter B, Anderson CP, Finch CE. Glial fibrillary acidic protein transcription responses to transforming growth factor-beta1 and interleukin-1beta are mediated by a nuclear factor-1-like site in the near-upstream promoter. Journal of Neurochemistry. 72: 1353-61. PMID 10098836 DOI: 10.1046/j.1471-4159.1999.721353.x  0.461
1996 Teter B, Rozovsky I, Krohn K, Anderson C, Osterburg H, Finch C. Methylation of the glial fibrillary acidic protein gene shows novel biphasic changes during brain development. Glia. 17: 195-205. PMID 8840161 DOI: 10.1002/(SICI)1098-1136(199607)17:3<195::AID-GLIA2>3.0.CO;2-0  0.484
1995 Rozovsky I, Laping NJ, Krohn K, Teter B, O'Callaghan JP, Finch CE. Transcriptional regulation of glial fibrillary acidic protein by corticosterone in rat astrocytes in vitro is influenced by the duration of time in culture and by astrocyte-neuron interactions. Endocrinology. 136: 2066-73. PMID 7720656 DOI: 10.1210/endo.136.5.7720656  0.488
1994 Laping NJ, Teter B, Nichols NR, Rozovsky I, Finch CE. Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors. Brain Pathology (Zurich, Switzerland). 4: 259-75. PMID 7952267 DOI: 10.1111/J.1750-3639.1994.Tb00841.X  0.502
1994 Laping NJ, Teter B, Anderson CP, Osterburg HH, O'Callaghan JP, Johnson SA, Finch CE. Age-related increases in glial fibrillary acidic protein do not show proportionate changes in transcription rates or DNA methylation in the cerebral cortex and hippocampus of male rats. Journal of Neuroscience Research. 39: 710-7. PMID 7897706 DOI: 10.1002/jnr.490390612  0.492
1994 Teter B, Finch CE, Condorelli DF. DNA methylation in the glial fibrillary acidic protein gene: map of CpG methylation sites and summary of analysis by restriction enzymes and by LMPCR. Journal of Neuroscience Research. 39: 708-9. PMID 7897705 DOI: 10.1002/jnr.490390611  0.443
1994 Teter B, Osterburg HH, Anderson CP, Finch CE. Methylation of the rat glial fibrillary acidic protein gene shows tissue-specific domains. Journal of Neuroscience Research. 39: 680-93. PMID 7897703 DOI: 10.1002/jnr.490390609  0.482
Show low-probability matches.